Skip to main content

Advertisement

Log in

NADPH oxidase-produced superoxide mediates EGFR transactivation by c-Src in arsenic trioxide-stimulated human keratinocytes

  • Inorganic compounds
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

Arsenic is a well-known poison and carcinogen in humans. However, it also has been used to effectively treat some human cancers and non-carcinogenic ailments. Previously, we demonstrated in keratinocytes that arsenic trioxide (ATO)-induced p21WAF1/CIP1 (p21) expression leading to cellular cytotoxicity through the c-Src/EGFR/ERK pathway and generation of reactive oxygen species (ROS). In this study, we found that EGFR-Y845 and EGFR-Y1173 could be phosphorylated by ATO. Using confocal microscopy and flow cytometry, we found that pretreatment with apocynin, DPI, and tiron could remove ATO-induced ROS production. Furthermore, to increase NADPH oxidase activity, ATO could induce cytosolic p67phox expression and translocation to membrane. In addition, knockdown of p67phox could abolish ATO-induced ROS production. Therefore, we suggest that NADPH oxidase-produced superoxide was a major source of ATO-induced ROS production. Conversely, ATO-induced NADPH oxidase activation and superoxide generation could be inhibited by the c-Src inhibitor PP1, but not by the EGFR inhibitor PD153035. In addition, overexpression of c-Src as well as treatment with ATO could stimulate EGFR-Y845/ERK phosphorylation, p21 expression, and cellular arrest/apoptosis, which could be attenuated by pretreatment with apocynin or knockdown of p67phox. Collectively, we suggest that NADPH oxidase was involved in the ATO-induced arrest/apoptosis of keratinocytes, which was regulated by c-Src activation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Babior BM (1999) NADPH oxidase: an update. Blood 93(5):1464–1476

    PubMed  CAS  Google Scholar 

  • Balaban RS, Nemoto S, Finkel T (2005) Mitochondria, oxidants, and aging. Cell 120(4):483–495

    Article  PubMed  CAS  Google Scholar 

  • Bedard K, Krause KH (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87(1):245–313

    Article  PubMed  CAS  Google Scholar 

  • Biscardi JS, Maa MC, Tice DA, Cox ME, Leu TH, Parsons SJ (1999) c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J Biol Chem 274(12):8335–8343

    Article  PubMed  CAS  Google Scholar 

  • Boerner JL, Demory ML, Silva C, Parsons SJ (2004) Phosphorylation of Y845 on the epidermal growth factor receptor mediates binding to the mitochondrial protein cytochrome c oxidase subunit II. Mol Cell Biol 24(16):7059–7071

    Article  PubMed  CAS  Google Scholar 

  • Campisi J (2005) Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120(4):513–522

    Article  PubMed  CAS  Google Scholar 

  • Chou WC, Jie C, Kenedy AA, Jones RJ, Trush MA, Dang CV (2004) Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and cytotoxicity in myeloid leukemia cells. Proc Natl Acad Sci USA 101(13):4578–4583

    Article  PubMed  CAS  Google Scholar 

  • Chowdhury AK, Watkins T, Parinandi NL et al (2005) Src-mediated tyrosine phosphorylation of p47phox in hyperoxia-induced activation of NADPH oxidase and generation of reactive oxygen species in lung endothelial cells. J Biol Chem 280(21):20700–20711

    Article  PubMed  CAS  Google Scholar 

  • Cooper KL, Liu KJ, Hudson LG (2009) Enhanced ROS production and redox signaling with combined arsenite and UVA exposure: contribution of NADPH oxidase. Free Radic Biol Med 47(4):381–388

    Article  PubMed  CAS  Google Scholar 

  • Cuadrado A, Garcia-Fernandez LF, Gonzalez L et al (2003) Aplidin™ induces apoptosis in human cancer cells via glutathione depletion and sustained activation of the epidermal growth factor receptor, Src, JNK, and p38 MAPK. J Biol Chem 278(1):241–250

    Article  PubMed  CAS  Google Scholar 

  • Demory ML, Boerner JL, Davidson R et al (2009) Epidermal growth factor receptor translocation to the mitochondria: regulation and effect. J Biol Chem 284(52):36592–36604

    Article  PubMed  CAS  Google Scholar 

  • DeYulia GJ Jr, Carcamo JM, Borquez-Ojeda O, Shelton CC, Golde DW (2005) Hydrogen peroxide generated extracellularly by receptor-ligand interaction facilitates cell signaling. Proc Natl Acad Sci USA 102(14):5044–5049

    Article  PubMed  CAS  Google Scholar 

  • Dilda PJ, Hogg PJ (2007) Arsenical-based cancer drugs. Cancer Treat Rev 33(6):542–564

    Article  PubMed  CAS  Google Scholar 

  • Efferth T, Li PC, Konkimalla VS, Kaina B (2007) From traditional Chinese medicine to rational cancer therapy. Trends Mol Med 13(8):353–361

    Article  PubMed  CAS  Google Scholar 

  • Flora SJ (2011) Arsenic-induced oxidative stress and its reversibility. Free Radic Biol Med 51(2):257–281

    Article  PubMed  CAS  Google Scholar 

  • Fruehauf JP, Meyskens FL Jr (2007) Reactive oxygen species: a breath of life or death? Clin Cancer Res 13(3):789–794

    Article  PubMed  CAS  Google Scholar 

  • Huang P, Feng L, Oldham EA, Keating MJ, Plunkett W (2000) Superoxide dismutase as a target for the selective killing of cancer cells. Nature 407(6802):390–395

    Article  PubMed  CAS  Google Scholar 

  • Huang HS, Chang WC, Chen CJ (2002) Involvement of reactive oxygen species in arsenite-induced downregulation of phospholipid hydroperoxide glutathione peroxidase in human epidermoid carcinoma A431 cells. Free Radic Biol Med 33(6):864–873

    Article  PubMed  CAS  Google Scholar 

  • Huang HS, Liu ZM, Ding L et al (2006) Opposite effect of ERK1/2 and JNK on p53-independent p21WAF1/CIP1 activation involved in the arsenic trioxide-induced human epidermoid carcinoma A431 cellular cytotoxicity. J Biomed Sci 13(1):113–125

    Article  PubMed  CAS  Google Scholar 

  • Jing Y, Dai J, Chalmers-Redman RM, Tatton WG, Waxman S (1999) Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood 94(6):2102–2111

    PubMed  CAS  Google Scholar 

  • Joo CK, Kim HS, Park JY, Seomun Y, Son MJ, Kim JT (2008) Ligand release-independent transactivation of epidermal growth factor receptor by transforming growth factor-beta involves multiple signaling pathways. Oncogene 27(5):614–628

    Article  PubMed  CAS  Google Scholar 

  • Klotz LO, Schieke SM, Sies H, Holbrook NJ (2000) Peroxynitrite activates the phosphoinositide 3-kinase/Akt pathway in human skin primary fibroblasts. Biochem J 352(Pt 1):219–225

    Article  PubMed  CAS  Google Scholar 

  • Lee IT, Wang SW, Lee CW et al (2008) Lipoteichoic acid induces HO-1 expression via the TLR2/MyD88/c-Src/NADPH oxidase pathway and Nrf2 in human tracheal smooth muscle cells. J Immunol 181(7):5098–5110

    PubMed  CAS  Google Scholar 

  • Lemarie A, Bourdonnay E, Morzadec C, Fardel O, Vernhet L (2008) Inorganic arsenic activates reduced NADPH oxidase in human primary macrophages through a Rho kinase/p38 kinase pathway. J Immunol 180(9):6010–6017

    PubMed  CAS  Google Scholar 

  • Leto TL, Morand S, Hurt D, Ueyama T (2009) Targeting and regulation of reactive oxygen species generation by Nox family NADPH oxidases. Antioxid Redox Signal 11(10):2607–2619

    Article  PubMed  CAS  Google Scholar 

  • Levy DE, Lapierre F, Liang W et al (1998) Matrix metalloproteinase inhibitors: a structure-activity study. J Med Chem 41(2):199–223

    Article  PubMed  CAS  Google Scholar 

  • Liao WT, Chang KL, Yu CL, Chen GS, Chang LW, Yu HS (2004) Arsenic induces human keratinocyte apoptosis by the FAS/FAS ligand pathway, which correlates with alterations in nuclear factor-κB and activator protein-1 activity. J Invest Dermatol 122(1):125–129

    Article  PubMed  CAS  Google Scholar 

  • Liu ZM, Huang HS (2006) As2O3-induced c-Src/EGFR/ERK signaling is via Sp1 binding sites to stimulate p21WAF1/CIP1 expression in human epidermoid carcinoma A431 cells. Cell Signal 18(2):244–255

    Article  PubMed  CAS  Google Scholar 

  • Liu ZM, Huang HS (2008a) Arsenic trioxide phosphorylates c-Fos to transactivate p21WAF1/CIP1 expression. Toxicol Appl Pharmacol 233(2):297–307

    Article  PubMed  CAS  Google Scholar 

  • Liu ZM, Huang HS (2008b) Inhibitory role of TGIF in the As2O3-regulated p21WAF1/CIP1 expression. J Biomed Sci 15(3):333–342

    Article  PubMed  CAS  Google Scholar 

  • Lu J, Chew EH, Holmgren A (2007) Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide. Proc Natl Acad Sci USA 104(30):12288–12293

    Article  PubMed  CAS  Google Scholar 

  • Lynn S, Gurr JR, Lai HT, Jan KY (2000) NADH oxidase activation is involved in arsenite-induced oxidative DNA damage in human vascular smooth muscle cells. Circ Res 86(5):514–519

    PubMed  CAS  Google Scholar 

  • Mathews V, George B, Lakshmi KM et al (2006) Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity. Blood 107(7):2627–2632

    Article  PubMed  CAS  Google Scholar 

  • Meves A, Stock SN, Beyerle A, Pittelkow MR, Peus D (2001) H2O2 mediates oxidative stress-induced epidermal growth factor receptor phosphorylation. Toxicol Lett 122(3):205–214

    Article  PubMed  CAS  Google Scholar 

  • Miller WH Jr, Schipper HM, Lee JS, Singer J, Waxman S (2002) Mechanisms of action of arsenic trioxide. Cancer Res 62(14):3893–3903

    PubMed  CAS  Google Scholar 

  • Moiseeva EP, Heukers R, Manson MM (2007) EGFR and Src are involved in indole-3-carbinol-induced death and cell cycle arrest of human breast cancer cells. Carcinogenesis 28(2):435–445

    Article  PubMed  CAS  Google Scholar 

  • Moiseeva O, Bourdeau V, Roux A, Deschenes-Simard X, Ferbeyre G (2009) Mitochondrial dysfunction contributes to oncogene-induced senescence. Mol Cell Biol 29(16):4495–4507

    Article  PubMed  CAS  Google Scholar 

  • Oakley FD, Abbott D, Li Q, Engelhardt JF (2009) Signaling components of redox active endosomes: the redoxosomes. Antioxid Redox Signal 11(6):1313–1333

    Article  PubMed  CAS  Google Scholar 

  • Platanias LC (2009) Biological responses to arsenic compounds. J Biol Chem 284(28):18583–18587

    Article  PubMed  CAS  Google Scholar 

  • Qian Y, Liu KJ, Chen Y, Flynn DC, Castranova V, Shi X (2005) Cdc42 regulates arsenic-induced NADPH oxidase activation and cell migration through actin filament reorganization. J Biol Chem 280(5):3875–3884

    Article  PubMed  CAS  Google Scholar 

  • Sato K, Sato A, Aoto M, Fukami Y (1995) c-Src phosphorylates epidermal growth factor receptor on tyrosine 845. Biochem Biophys Res Commun 215(3):1078–1087

    Article  PubMed  CAS  Google Scholar 

  • Sato K, Nagao T, Iwasaki T, Nishihira Y, Fukami Y (2003) Src-dependent phosphorylation of the EGF receptor Tyr-845 mediates Stat-p21waf1 pathway in A431 cells. Genes Cells 8(12):995–1003

    Article  PubMed  CAS  Google Scholar 

  • Simeonova PP, Luster MI (2002) Arsenic carcinogenicity: relevance of c-Src activation. Mol Cell Biochem 234–235(1–2):277–282

    Article  PubMed  Google Scholar 

  • Smith KR, Klei LR, Barchowsky A (2001) Arsenite stimulates plasma membrane NADPH oxidase in vascular endothelial cells. Am J Physiol Lung Cell Mol Physiol 280(3):L442–L449

    PubMed  CAS  Google Scholar 

  • Tanaka-Kagawa T, Hanioka N, Yoshida H, Jinno H, Ando M (2003) Arsenite and arsenate activate extracellular signal-regulated kinases 1/2 by an epidermal growth factor receptor-mediated pathway in normal human keratinocytes. Br J Dermatol 149(6):1116–1127

    Article  PubMed  CAS  Google Scholar 

  • Tonks NK (2005) Redox redux: revisiting PTPs and the control of cell signaling. Cell 121(5):667–670

    Article  PubMed  CAS  Google Scholar 

  • Trachootham D, Alexandre J, Huang P (2009) Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8(7):579–591

    Article  PubMed  CAS  Google Scholar 

  • Ushio-Fukai M (2009) Compartmentalization of redox signaling through NADPH oxidase-derived ROS. Antioxid Redox Signal 11(6):1289–1299

    Article  PubMed  CAS  Google Scholar 

  • Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39(1):44–84

    Article  PubMed  CAS  Google Scholar 

  • Wang J, Li L, Cang H, Shi G, Yi J (2008) NADPH oxidase-derived reactive oxygen species are responsible for the high susceptibility to arsenic cytotoxicity in acute promyelocytic leukemia cells. Leuk Res 32(3):429–436

    Article  PubMed  CAS  Google Scholar 

  • Wetzker R, Bohmer FD (2003) Transactivation joins multiple tracks to the ERK/MAPK cascade. Nat Rev Mol Cell Biol 4(8):651–657

    Article  PubMed  CAS  Google Scholar 

  • Yu HS, Liao WT, Chai CY (2006) Arsenic carcinogenesis in the skin. J Biomed Sci 13(5):657–666

    Article  PubMed  CAS  Google Scholar 

  • Zhang P, Wang YZ, Kagan E, Bonner JC (2000) Peroxynitrite targets the epidermal growth factor receptor, Raf-1, and MEK independently to activate MAPK. J Biol Chem 275(29):22479–22486

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work has been granted by the National Science Council of Taiwan (grant numbers: NSC95-2320-B-006-055-MY3 and NSC98-2320-B-006-008-MY3).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Huei-Sheng Huang.

Electronic supplementary material

Below is the link to the electronic supplementary material.

204_2012_856_MOESM1_ESM.pdf

Requirement of c-Src activation in ATO-induced EGFR/ERK phosphorylation and p21 expression. a HaCaT cells were treated with 20 μM ATO for the indicated time periods. Total cell lysates were analyzed by Western blot with specific antibodies as indicated. (PDF 59 kb)

204_2012_856_MOESM2_ESM.pdf

Biosynthesis of p67phox in response to ATO. a Cells were treated with 20 μM ATO for various time periods as indicated. Total RNA was extracted and p67Phox mRNA expression was examined by real-time PCR. b Cell lysates were also collected to detect p67phox and β-actin protein expression by Western blot.(PDF 26 kb)

204_2012_856_MOESM3_ESM.pdf

Overexpression of wtSrc can induce EGFR-Y845 phosphorylation and p21 expression. a A431 cells or (b) HaCaT cells were transfected with wtSrc for 24 h, then the total cell lysates were collected and analyzed by Western blot with specific antibodies as indicated. c A431 cells were transfected with wtSrc for 24 h, followed by treatment with various doses of apocynin for 1 h. Total cell lysates were collected and analyzed by Western blot with specific antibodies as indicated. (PDF 201 kb)

204_2012_856_MOESM4_ESM.pdf

Involvement of c-Src/NADPH oxidase signaling in ATO-induced cellular arrest/apoptosis of HaCaT. Cells were transfected with various doses of wtSrc for different time periods. a Cell numbers were counted after staining with trypan blue in HaCaT cells. Cells were transiently transfected with empty vectors or 2 μg of shRNA of p67Phox for 24 h, followed by treatment with or without 20 μM ATO for 24 h as indicated. Then, the cell death assay was performed as described previously. (PDF 132 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tseng, HY., Liu, ZM. & Huang, HS. NADPH oxidase-produced superoxide mediates EGFR transactivation by c-Src in arsenic trioxide-stimulated human keratinocytes. Arch Toxicol 86, 935–945 (2012). https://doi.org/10.1007/s00204-012-0856-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-012-0856-9

Keywords

Navigation